Evidence map›Paper›PMID 31741136›Full record

ArticleEuropean journal of epidemiology2020

Serum albumin and atrial fibrillation: insights from epidemiological and mendelian randomization studies.

Li-Zhen Liao, Shao-Zhao Zhang, Wei-Dong Li, Ying Liu, Jia-Ping Li, Xiao-Dong Zhuang, Xin-Xue Liao

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of epidemiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 3 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 3 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Li-Zhen LiaoGuangzhou Higher Education Mega Center, Guangdong Pharmaceutical University, Guangzhou, Guangdong, People's Republic of China.
Shao-Zhao ZhangCardiology Department, The First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan 2nd Road, Yue Xiu, Guangzhou, 510080, Guangdong, People's Republic of China.
Wei-Dong LiGuangzhou Higher Education Mega Center, Guangdong Pharmaceutical University, Guangzhou, Guangdong, People's Republic of China.
Ying LiuGuangzhou Higher Education Mega Center, Guangdong Pharmaceutical University, Guangzhou, Guangdong, People's Republic of China.
Jia-Ping LiDepartment of Interventional Radiology, The First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan 2nd Road, Yue Xiu, Guangzhou, 510080, Guangdong, People's Republic of China.
Xiao-Dong ZhuangCardiology Department, The First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan 2nd Road, Yue Xiu, Guangzhou, 510080, Guangdong, People's Republic of China. zhuangxd3@mail.sysu.edu.cn.
Xin-Xue LiaoCardiology Department, The First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan 2nd Road, Yue Xiu, Guangzhou, 510080, Guangdong, People's Republic of China. liaoxinx@mail.sysu.edu.cn.
Guangdong Pharmaceutical University · CNSun Yat-sen University · CNThe First Affiliated Hospital, Sun Yat-sen University · CN

Funding

National Natural Science Foundation of China 81701378
6 · The paper itself

Abstract

Atrial fibrillation (AF) is the most common arrhythmia in clinical practice. Low serum albumin level is linked to the emergence of many cardiovascular diseases, including AF. In this study, we aim to characterize the nature and magnitude of the prospective association between serum albumin and incident AF in the Atherosclerosis Risk in Communities (ARIC) Study and investigate any causal relevance to the association between them. ARIC Study is a population-based, prospective, cohort study of cardiovascular risk factors in four US communities, initially consisting of 15,792 participants, aged 45-64 years, recruited between 1987 and 1989 (visit 1). The final sample size was 12,833 in this study. Baseline (visit 1) characteristics were compared between groups using one-way ANOVA test, Chi square test, or Kruskal-Wallis test as appropriate. We used multivariable Cox' hazard regression models to assess the association between albumin and incident AF. Two-sample Mendelian randomization (MR) based on publicly available summary-level data from genome-wide association studies was used to estimate the causal influence of the serum albumin and incident AF. During a median follow-up of 25.1 years, 2259 (17.6%) participants developed incident AF. After multiple adjustment, serum albumin was inversely associated with incidence of AF [HR = 0.90, 95% CI 0.86-0.94, per SD (0.27 g/dL) increase; HR = 0.80, 95% CI 0.71-0.91, Q4 vs. Q1]. In MR analysis, we detected no evidence for a causal relation between serum albumin level and AF in inverse-variance weighted (IVW) method (odds ratio: 0.996, 95% CI 0.980-1.012, per 1 g/dL increase of albumin; P = 0.620) without evidence of heterogeneity between estimates from individual SNPs (P

Indexed as

Mendelian Randomization AnalysisAtrial FibrillationCohort StudiesFemaleGenome-Wide Association StudyHumansIncidenceMaleMiddle AgedPolymorphism, Single NucleotideProspective StudiesSerum AlbuminUnited StatesSerum AlbuminAtrial fibrillationGenome wide association studyMendelian randomizationSerum albumin

Identifiers

PMID31741136
OpenAlexW2988294201

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.